CRINONE

This brand name is authorized in Australia, Brazil, Canada, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug CRINONE contains one active pharmaceutical ingredient (API):

1 Progesterone
UNII 4G7DS2Q64Y - PROGESTERONE

Progesterone is a natural progestogen, the main hormone of the corpus luteum and the placenta. It acts on the endometrium by converting the proliferating phase to the secretory phase.

Read about Progesterone

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
CRINONE Vaginal gel Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
G03DA04 Progesterone G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03D Progestogens → G03DA Pregnen (4) derivatives
Discover more medicines within G03DA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 6366C
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 525421601164310, 525421602160319
Country: CA Health Products and Food Branch Identifier(s): 02241013
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 2385-MEE-0816
Country: EE Ravimiamet Identifier(s): 1134548, 1634846, 1634857, 1765919, 1765920
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 62915
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 053843
Country: FR Base de données publique des médicaments Identifier(s): 65015968
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 42123
Country: HK Department of Health Drug Office Identifier(s): 44527
Country: IE Health Products Regulatory Authority Identifier(s): 18927, 18928, 36553, 54352
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 6538
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1072219, 1076147, 1093375
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 303M97
Country: NL Z-Index G-Standaard, PRK Identifier(s): 129402
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 10232
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100339095, 100459097
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W61888001, W61888002
Country: SG Health Sciences Authority Identifier(s): 10884P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699777342035
Country: US FDA, National Drug Code Identifier(s): 0023-6150, 0023-6151, 52544-256
Country: ZA Health Products Regulatory Authority Identifier(s): A38/21.8.2/0615

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.